EarningsQ4 2020 Earnings Report

Dianthus Therapeutics (87E) Q4 2020 Earnings Report

0 Followers

DE:87E Q4 2020 EPS Results

Actual EPS-€5.37

Consensus EPS-€5.48

Beat/MissBeat by +€0.11

One Year Ago EPS-€8.33

Actual Revenue€0.00

Expected Revenue€0.00

Beat/MissMet expectations

YoY Revenue Growth―

QuarterQ4 2020

Date03/03/2021

TimeTBA

Conference CallWednesday, March 3, 2021

DE:87E Upcoming Earnings

Dianthus Therapeutics's next earnings date is estimated for November 5, 2026, based on past reporting schedules.

No earnings call audio is available for this earnings event.

No slide deck is available for this earnings event.

No earnings call summary is available for this earnings event.

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change
Nov 05, 2026	2026 (Q3)	-0.83 / -	-0.856	―
Aug 04, 2026	2026 (Q2)	-0.75 / -0.79	-0.777	-2.27% (-0.02)
May 05, 2026	2026 (Q1)	-0.95 / -0.75	-0.724	-3.66% (-0.03)
Mar 09, 2026	2025 (Q4)	-0.89 / -1.26	-0.715	-76.54% (-0.55)
Nov 05, 2025	2025 (Q3)	-0.77 / -0.86	-0.653	-31.08% (-0.20)
Aug 07, 2025	2025 (Q2)	-0.77 / -0.78	-0.45	-72.55% (-0.33)
May 12, 2025	2025 (Q1)	-0.75 / -0.72	-0.477	-51.85% (-0.25)
Mar 11, 2025	2024 (Q4)	-0.75 / -0.72	-0.627	-14.08% (-0.09)
Nov 07, 2024	2024 (Q3)	-0.53 / -0.65	-3.337	80.42% (+2.68)
Aug 08, 2024	2024 (Q2)	-0.48 / -0.45	-2.754	83.65% (+2.30)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed